6-chloro-2-(4-methylphenyl)amino-3-nitro-benzoic acid | 55830-46-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 6-chloro-2-(4-methylphenyl)amino-3-nitro-benzoic acid
• 英文别名: 6-chloro-2-(4-methylanilino)-3-nitrobenzoic acid
• CAS: 55830-46-1
• 化学式: C₁₄H₁₁ClN₂O₄
• 分子量: 306.705
• InChiKey: ZUBCTKIBKXPNGZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  21
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  95.2
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  6-chloro-2-(4-methylphenyl)amino-3-nitro-benzoic acid 在 N,N-二甲基苯胺 、 三氯氧磷 作用下， 以 氯仿 为溶剂， 反应 3.0h， 以87%的产率得到1-Chlor-7-methyl-4-nitro-acridon
  参考文献：
  名称：

  2-(Aminoalkyl)-5-nitropyrazolo[3,4,5-kl]acridines, a new class of anticancer agents

  摘要：

  2-(Aminoalkyl)-5-nitropyrazolo[3,4,5-kl]acridines were prepared from substituted anilines via the 1-chloro-4-nitroacridones followed by condensation with [(alkylamino)alkyl]hydrazines. Impressive activity was demonstrated for the 9-hydroxy, 9-alkoxy, and 9-acyloxy analogs in vitro on a L1210 leukemia line and in vivo against the P388 leukemia. Advanced studies led to the selection of 3bbb for clinical trial.

  DOI：

  10.1021/jm00104a001
• 作为产物：
  描述：

  2,6-二氯-3-硝基苯甲酸 、 乙烷,三氯氟- 以 N,N-二甲基苯胺 为溶剂， 生成 6-chloro-2-(4-methylphenyl)amino-3-nitro-benzoic acid
  参考文献：
  名称：

  Pyrazolo[3,4,5-kl]acridine compositions and methods for their production

  摘要：

  吡唑并[3,4,5-kl]蒽啉被描述为抗菌剂和抗肿瘤剂，以及它们的制备方法和药物组合物。

  公开号：

  US04555572A1

文献信息

• Pyrazolo[3,4,5-kl]acridine compositions and methods for their production
  申请人：Warner-Lambert Company

  公开号：US04555572A1

  公开（公告）日：1985-11-26

  Pyrazolo[3,4,5-kl]acridines are described as antibacterial agents and antitumor agents as well as pharmaceutical compositions and methods for their preparation.

  吡唑并[3,4,5-kl]蒽啉被描述为抗菌剂和抗肿瘤剂，以及它们的制备方法和药物组合物。
• 1,8-NAPHTHALIMIDE IMIDAZO{4,5,1-DE}ACRIDONES WITH ANTI-TUMOR ACTIVITY
  申请人：——

  公开号：US20030203916A1

  公开（公告）日：2003-10-30

  The invention provides imidazoacridone compounds of general formula (1) which have cytotoxic and anti-tumor activity. The invention also provides methods of preparing the compounds, and methods of using the compounds for the treatment of cancer or other mammalian diseases characterized by undesirably high levels of cell proliferation. The compounds of the invention are also expected to have utility as research tools. 1

  该发明提供了一般式（1）的咪唑喹啉酮化合物，具有细胞毒性和抗肿瘤活性。该发明还提供了制备这些化合物的方法，以及利用这些化合物治疗癌症或其他哺乳动物疾病的方法，这些疾病具有细胞增殖水平过高的特征。该发明的化合物还有望作为研究工具具有实用性。
• Pyrazolo[3,4,5-k1]acridine compositions and methods for their use as
  申请人：Warner-Lambert Company

  公开号：US04588730A1

  公开（公告）日：1986-05-13

  Pyrazolo[3,4,5-k1]acridines are described as antibacterial agents and antitumor agents as well as pharmaceutical compositions and methods for their preparation.

  Pyrazolo[3,4,5-k1]acridines被描述为抗菌剂和抗肿瘤剂，以及药物组合物和其制备方法。
• Method of treating leukemia with pyrazolo[3,4,5-kl]acridines
  申请人：Warner-Lambert Company

  公开号：US04621086A1

  公开（公告）日：1986-11-04

  Pyrazolo[3,4,5-kl]acridines are described as antibacterial agents and antitumor agents as well as pharmaceutical compositions and methods for their preparation.

  Pyrazolo[3,4,5-kl]acridines被描述为抗菌剂和抗肿瘤剂，以及其制备的药物组合物和方法。
• Imidazoacridine Compounds for Treating FLT3-Mediated Disorders
  申请人：Ajami Alfred M.

  公开号：US20100016300A1

  公开（公告）日：2010-01-21

  A method of treating a FLT3-mediated condition in a patient in need thereof, comprising administering to the patient a therapeutically effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof: (I), The conditions that can be treated by the compounds of the present invention and the definitions for the variables in formula (I) are provided herein.

  一种治疗FLT3介导的疾病的方法，包括向需要治疗的患者给予化合物(I)或其药学上可接受的盐的治疗有效量：(I)。本发明的化合物可以治疗以下疾病，公式(I)中变量的定义在此提供。